T. Rowe Price Associates’s GoodRx Holdings GDRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.66M | Buy |
|
|||||
|
2025
Q2 | $1.28M | Buy |
|
|||||
|
2025
Q1 | $1.12M | Sell |
|
|||||
|
2024
Q4 | $1.19M | Buy |
|
|||||
|
2024
Q3 | $1.38M | Buy |
|
|||||
|
2024
Q2 | $143K | Buy |
|
|||||
|
2024
Q1 | $102K | Hold |
|
|||||
|
2023
Q4 | $96K | Hold |
|
|||||
|
2023
Q3 | $81K | Sell |
|
|||||
|
2023
Q2 | $105K | Hold |
|
|||||
|
2023
Q1 | $119K | Sell |
|
|||||
|
2022
Q4 | $117K | Hold |
|
|||||
|
2022
Q3 | $118K | Buy |
|
|||||
|
2022
Q2 | $143K | Buy |
|
|||||
|
2022
Q1 | $282K | Buy |
|
|||||
|
2021
Q4 | $304K | Sell |
|
|||||
|
2021
Q3 | $431K | Buy |
|
|||||
|
2021
Q2 | $248K | Sell |
|
|||||
|
2021
Q1 | $293K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $125M | Buy |
|